Human ovarian cancer of the surface epithelium (Q41615934)

5 October 2017

1 reference

title

Human ovarian cancer of the surface epithelium (English)

1 reference

5 October 2017

1 reference

A. Berchuck

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9337069

20 November 2024

M. Carney

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9337069

20 November 2024

language of work or name

English

0 references

publication date

1 September 1997

1 reference

full work available at URL

5 October 2017

https://api.elsevier.com/content/article/PII:S0006295297000610?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0006-2952(97)00061-0

https://api.elsevier.com/content/article/PII:S0006295297000610?httpAccept=text/plain

20 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0006-2952(97)00061-0

20 November 2024

published in

Biochemical Pharmacology

1 reference

5 October 2017

1 reference

5 October 2017

1 reference

5 October 2017

page(s)

541-544

1 reference

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

Ovarian tumors of the hen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

Prognostic significance of HER-2/neu expression in advanced epithelial ovarian cancer: a multivariate analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

NEU protein overexpression in benign, borderline, and malignant ovarian neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

Somatic activation of rasK gene in a human ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

c-myc over-expression in human primary ovarian tumours: its relevance to tumour progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

Transforming growth factor-beta and ovarian carcinoma cells: regulation of proliferation and surface antigen expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

Transforming growth factor beta 1 (TGF-beta 1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

Growth regulation of ovarian cancer cells by epidermal growth factor and transforming growth factors alpha and beta 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

Unusual antiproliferative effects of transforming growth factors-beta 1 and beta 2 against primary cells from human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

BRCA1 mutations in primary breast and ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900061-0

The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(97)00061-0

Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(97)00061-0

K-ras activation in neoplasms of the human female reproductive tract

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(97)00061-0

Evidence against ras activation in human ovarian carcinomas

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(97)00061-0

p53 and Ki-ras gene mutations in epithelial ovarian neoplasms

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(97)00061-0

Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(97)00061-0

Overexpression and mutation of p53 in epithelial ovarian cancer

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(97)00061-0

Mutation and overexpression of p53 in early-stage epithelial ovarian cancer

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(97)00061-0

p53 gene mutations and protein accumulation in human ovarian cancer

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(97)00061-0

20 November 2024

Identifiers

DOI

1 reference

5 October 2017

1 reference